We consider a Bayesian random effects model that is commonly used in meta-analysis, in which the random effects have a t distribution, with degrees of freedom parameter to be estimated. We develop a Markov chain Monte Carlo algorithm for estimating the posterior distribution in this model, and establish geometric convergence of the algorithm. The geometric convergence rate has important theoretical and practical ramifications. Indeed, it implies that, under standard second moment conditions, the ergodic averages used to estimate posterior quantities of interest satisfy central limit theorems. Moreover, it guarantees the consistency of a batch means estimate of the asymptotic variance in the CLT, which in turn allows for the construction of asymptotically valid standard errors. We show how our Markov chain can be used, in conjunction with an importance sampling method, to carry out an empirical Bayes approach for estimating the degrees of freedom parameter. To illustrate our methodology we consider a meta-analysis of studies that link intake of non-steroidal anti-inflammatory drugs to a reduction in colon cancer risk, in which some of the studies are outliers. To model the distribution of the study effects we consider the family of t distributions, as well as a family of mixtures of Dirichlet process priors centered at the t distributions, and show how our methodology can be used to make a choice of model.
Whereas the normality assumption in line (1.1a) is typically supported by some theoretical result, such as the asymptotic normality of maximum likelihood estimates, the normality assumption in line (1.1b) generally doesn't have any justification and is made solely for the sake of convenience. In certain situations, for example when study effects are highly disparate and one wishes to accommodate outliers, a good alternative to line (1.1b)
, where t d (µ, τ 2 ) is the t distribution with d degrees of freedom, location µ, and scale τ . We will then want to select d, with the choice d = ∞ signifying the choice of the normal distribution. In all of the many previous uses of this model, the degrees of freedom parameter has been chosen in an ad-hoc manner [see, e.g., Smith et al. (1995) and Gelman et al. (2004, sect. 17.4) , among many others]-with a decision on whether to use a t rather than a normal often based on whether or not inferences are different-and subsequent inference carried out without careful consideration of the validity of the inference.
Here we seek a principled approach for specifying the degrees of freedom parameter.
Denote Y = (Y 1 , . . . , Y K ) T and θ = (θ 1 , . . . , θ K ) T . Let ρ d be the prior density of (θ, µ, τ ) specified by model (1.1) when we use a t distribution with d degrees of freedom instead of a normal in (1.1b), and let ρ d,y be the corresponding posterior given Y = y. The marginal density of Y is given by
where y (θ) is the likelihood function specified in (1.1a). For convenience of notation, ρ ∞ , ρ ∞,y and m ∞ (y) will denote the corresponding quantities when a normal distribution is used in (1.1b). An empirical Bayes approach selects the value of d that maximizes m d (we now suppress the dependence of m d (y) on y, since y is fixed throughout). In principle, the maximizing value of d can be obtained via the EM algorithm, by treating θ as missing.
Implementation of the EM algorithm appears to present some nontrivial issues; but a more significant problem is that it gives only the maximizing value, whereas in the present situation it is also of interest to know the entire marginal likelihood function m d . For example, in one of the two illustrations in Section 4, the likelihood at ∞ is nearly the same as the likelihood at the maximum (see Figure 2 (A)), and this is useful to know, since we would not use a t model if we knew that a normal model is adequate.
To discuss estimation of m d as d varies, define the Bayes factor for the model based on the t distribution with d degrees of freedom vs. the model based on the normal distribution by 
Indeed, we havê
When we present an estimate such as (1.3), it is important to also provide error margins for the estimate and unfortunately, this is rarely done with estimates produced by MCMC (Flegal et al. 2008) ; we return to this point in Section 5 of the present paper. Now, whereas the almost sure convergence in (1.4) results from simple ergodicity of the chain, a central limit theorem, which is required in order to produce asymptotically valid standard errors, requires further regularity conditions. To be specific, suppose that we want to estimate the posterior expectation of some function g(θ, µ, τ ). The ergodic theorem implies that
) is a strongly consistent estimator. However, a central limit theorem for this estimator may not exist unless (i) the Markov chain mixes fast enough and (ii) the random variable g(θ, µ, τ ) has enough moments (with respect to ρ ∞,y ). Various sets of conditions exist (Chan and Geyer 1994 ) but here we mention only that a typical condition is that the Markov chain is geometrically ergodic and that g(θ, µ, τ ) has a finite moment of order 2 + , for some > 0.
Geometric ergodicity of the standard Markov chains for dealing with model (1.1), a fixed scan Gibbs and a block Gibbs sampler, was established by Hobert and Geyer (1998) . Unfortunately, the moment condition is problematic: the random variable
does not even have a finite second moment when (θ, µ, τ ) ∼ ρ ∞,y , because the tails of the t distribution are much heavier than those of the normal. Thus, the standard chains yield a Bayes factor estimate which does not satisfy a CLT, and since there is no CLT, the target parameter that the usual methods of estimating standard errors (such as those based on batch means and regeneration) are designed to estimate is not even defined.
Suppose that instead we run a chain based on model (1.1), but with a t distribution with
has moments of all orders when (θ, µ, τ ) ∼ ρ d 1 ,y , and so the estimatê
(1.5)
will satisfy a central limit theorem if we can establish geometric ergodicity of the chain.
In this paper we present an efficient Markov chain algorithm for estimating the posterior distribution for model (1.1) with a t distribution in line (1.1b), and establish geometric ergodicity of the chain. The benefits of these results are that they enable us to deal with the preliminary model choice issue of selecting the degrees of freedom parameter; and once we have decided on the model and run a Markov chain for that model, the combination of a central limit theorem and a method for estimating the variance such as batching will allow us to get valid error margins for estimates we obtain in subsequent inference. Our development puts the use of this model on a firm footing, which is useful since this is one of the most commonly used models in applied Bayesian work.
There is a close correspondence between our random effects model and the one considered by Hobert and Geyer (1998) . Consequently, the associated block Gibbs samplers are also similar, although there are some significant differences; e.g., our algorithm has three steps per iteration while theirs has only two. Due to the similarity between the two algorithms, we are able to exploit a few of the simple (exact) expectation calculations from Hobert and Geyer (1998) in the early stages of our proof of geometric ergodicity. However, the latter part of the proof contains new analysis.
This paper is organized as follows. In Section 2 we describe a model that is equivalent to the version of model (1.1) in which the distribution of the random effects is a t, and describe the Gibbs sampling algorithm. In Section 3 we state and prove a theorem that asserts that our Markov chain is geometrically ergodic, and discuss estimation of variability.
Section 4 gives an illustration of the use of Bayes factors to select the model in a metaanalysis example. Section 5 contains closing remarks that include a discussion of results on geometric ergodicity in concrete models of statistical interest.
2 Models and a Gibbs Sampling Algorithm
A Hierarchical Model With t-Distributed Random Effects
Consider the following hierarchical model:
where at the bottom level µ and λ θ are independent. In (2.1a) and (2.1b), γ i = 1/σ 2 i and λ θ = 1/τ 2 ; it is much more convenient to work with the γ i 's and λ θ . Note that (2.1) is the same as (1.1) except that we have a t distribution instead of a normal in the middle of the hierarchy. As mentioned earlier, we assume that experiment i gives an estimateγ i that is for practical purposes equal to γ i . This is commonly done and does not present a problem unless the individual studies involve very small samples (DuMouchel 1990) , in which situation one would want to put prior distributions on the γ i 's. For definiteness, we note that by X ∼ Gam(α, β) we mean X is a random variable supported on the positive half-line with density proportional to x α−1 e −xβ , and by
the prior density of (θ, µ, λ θ ) under this model, and let π y denote the posterior density given
Now consider a more complex hierarchical model given by
where λ = (λ 1 , . . . , λ K ) T , and at the bottom level everything is independent. For this model, let π * and π * y denote the prior and posterior densities of (θ, λ, µ, λ θ ), respectively, and let m * (y) denote the marginal density of Y .
We will write π y (θ, µ, λ θ ) and π(θ, µ, λ θ | y) interchangeably, and we will slightly abuse notation and use π generically to denote various distributions under model (2.1), e.g. π(θ), π(µ), and π(λ θ ) will denote the marginal distributions of θ, µ, and λ θ , respectively. A similar remark applies to π * . Also, even though π, π y , π * , π * y and m * all depend on d, this dependence is suppressed, since d is now fixed.
Clearly,
does not depend on λ, µ, and λ θ , and this is the function that was denoted y (θ) in Section 1.
The posterior marginal density of
(This is the standard calculation that shows that a t distribution may be viewed as a gamma mixture of scaled normals.)
We conclude that π * (θ, µ, λ θ | y) = π(θ, µ, λ θ | y). Hence, if we can develop an MCMC algorithm with stationary density π * (θ, λ, µ, λ θ | y), then we can use this MCMC algorithm to study π(θ, µ, λ θ | y)-we just throw away the λ's.
We note that the prior in (2.1c) specifies that µ and λ θ are independent. This is different from another "normal / inverse gamma" prior in which λ θ ∼ Gam(α, β), and given λ θ ,
, which is often used because it is conjugate to the normal distribution with two parameters unknown (see e.g. Berger 1985, p. 288) . In our situation, there is no reason to prefer this normal / inverse gamma prior.
Conditional Distributions and a Gibbs Sampler
Let ζ = (θ 1 , . . . , θ K , µ) T . We will consider a block Gibbs sampler whose components are
(In what is below, the data vector Y is fixed, and all distributions are conditional on Y = y, although this conditioning is not stated explicitly.) It is easy to show that
It is also easy to show that
Now, it follows from (2.3) that the conditional density of ζ given λ and λ θ is proportional to
From this we deduce that given λ and λ θ , ζ has a multivariate normal distribution. All we have to do is identify the mean vector and the covariance matrix. This unnormalized multivariate normal density is nearly identical to the corresponding density in Hobert and Geyer's (1998) block Gibbs sampler, and the calculations we now perform to identify the mean and covariance matrix follow theirs closely. First, the covariance matrix, V , satisfies
The mean, ζ 0 , is the solution to
Write the Cholesky factorization of the precision matrix as
where L is a lower-triangular matrix. The elements of L can be calculated "by hand" and it is straightforward to show that
where c T is a 1 × K row vector whose i-th element is λ θ λ i /d ii . We can now easily compute
To simulate from the conditional distribution of ζ given λ, λ θ , draw a (K + 1)-variate standard normal, Z, and take (L −1 ) T Z + ζ 0 . We now have all the conditional distributions needed to implement a Gibbs sampler on (λ θ , λ, ζ).
Next we give the variances and covariances (that is, the elements of V ), along with upper bounds that will be used later. We have
Moreover,
Note that E(µ | λ θ , λ) is a convex combination of the y j 's and µ 0 . Thus, it is uniformly bounded by a constant. Also,
This shows that E(θ i | λ θ , λ) is a convex combination of E(µ | λ θ , λ) and y i , so is also uniformly bounded by a constant.
Geometric Ergodicity and Valid Estimates of Variability

Geometric Ergodicity
Consider a block-Gibbs sampler on the state space
that updates λ, then λ θ , then ζ; that is, if we write the current state as (λ , λ θ , ζ ) and the next state as (λ, λ θ , ζ), then the Markov transition density is given by
Let K m (x, ·) denote the m-step Markov transition distribution corresponding to (3.1), and let Π * y denote the distribution corresponding to π * y .
Harris Ergodicity of the chain governed by (3.1) is the condition that K m (x, ·) − Π * y (·) → 0 for all x ∈ X , where · denotes supremum over all Borel subsets of X .
This condition is guaranteed by the so-called "usual regularity conditions," namely that the chain has an invariant probability measure, is irreducible, aperiodic, and Harris recurrent; see Theorem 13.0.1 of Meyn and Tweedie (1993) . These usual regularity conditions are typically easy to check; they are implied for example if the Markov transition function has a density which is everywhere positive, which is the case for (3.1). Geometric ergodicity is the much stronger condition that there exist a constant c ∈ [0, 1) and a function
Theorem 1 The chain driven by (3.1) is geometrically ergodic.
Proof As in Hobert and Geyer (1998), we will prove that the Gibbs sampler is geometrically ergodic by finding a "drift function" w :
where ρ ∈ (0, 1), L ∈ R, and where the expectation is taken with respect to the transition density in (3.1).
We will need to calculate some conditional expectations with respect to the transition density in (3.1). We use "last" as a shorthand for the variables of the last iteration, i.e.
(λ , λ θ , ζ ). Conditional expectations given "last" are computed iteratively as follows:
Define the following functions:
where c is a positive constant. Our drift function will take the form w = 7 i=1 A i w i where the A i 's are positive constants to be determined. By definition, the function w is unbounded off compact sets if
(see Meyn and Tweedie 1993, p. 191) . However since w is continuous, to show (3.2) it is enough to show that |θ i | is bounded for each i, |µ| is bounded, λ θ is bounded away from both 0 and ∞, and the same is true for the λ i 's. Since w 5 → ∞ as λ θ → ∞ and w 1 → ∞ as λ θ → 0, we know that λ θ is contained as specified. A similar argument involving w 6 and w 2
shows that the λ i 's are also contained. Since w 4 → ∞ as |θ i | → ∞, we have θ i contained, and given that θ i is contained, w 3 → ∞ as |µ| → ∞ so µ is contained as well. We conclude that w is unbounded off compact sets.
We now start computing the required expectations. The terms w 5 and w 6 are easy to bound. Let 0 < c < min{β, d/2} and note that
where "const" is a quantity that is independent of any variables (it does of course depend on K and the hyperparameters). Similarly,
Hence, E e cλ θ last ≤ const and E e cλ i last ≤ const.
Using the inequalities stated at the end of Section 2.2, we have
Now, as long as K ≥ 2, K 2 + α > 1, and we have
Hence,
w 3 (ζ ).
Jensen's inequality implies that
where a is a positive constant. A second application of Jensen's inequality gives
Hence, E(w 7 (λ θ , ζ) | last) ≤ const. Now, choose any ρ ∈ (0, 1) and define
Let A 3 = A 4 = · · · = A 7 = 1. Putting everything together, we have
The chain is therefore geometrically ergodic.
Let x 0 , x 1 , . . . be a Markov chain driven by (3.1), let l be a real-valued function of x, and suppose we wish to form confidence intervals for the posterior expectation of l(x).
Suppose the chain is geometrically ergodic and there exists > 0 such that E |l(x)| 2+ < ∞. Theorem 18.5.3 of Ibragimov and Linnik (1971) implies that, with Var(l(x 0 )) and Cov(l(x 0 ), l(x j )) calculated under the assumption that x 0 has the stationary distribution, the series
converges absolutely, and if κ 2 > 0, then with x 0 having an arbitrary distribution, the
Construction of Valid Standard Error Estimates
The existence of the CLT for l n is important from a practical standpoint. Indeed, in conjunction with a consistent estimator of the asymptotic variance, it allows for the construction of a valid asymptotic standard error for l n . There are many ways to estimate the asymptotic variance. The standard methods are batch means (Jones et al. 2006) , spectral methods (Geyer 1992) , and regenerative simulation (Mykland et al. 1995) . Each of these estimators is consistent under regularity conditions that include geometric ergodicity of the Markov chain. Batch means, which is the simplest of the three methods to implement, is the one we use in our examples.
Anti-Inflammatory Drugs and Risk of Colon Cancer
An important application of random effects models is in the area of meta-analysis. Here we study a body of literature that considers the effect of non-steroidal anti-inflammatory drugs (NSAIDs) on the risk of colon cancer, a subject currently of considerable interest and controversy in the medical literature (see, e.g. Iwama 2009 ).
Over the last 15 years, a large number of studies have investigated the relationship between use of NSAIDs and development of colon cancer, either at the epidemiological or at the cellular and molecular level, and several have strongly suggested that long-term use of NSAIDs significantly decreases the risk of colon cancer. But the studies have been inconsistent, with some suggesting a weak beneficial effect and one even suggesting a negative effect. Harris et al. (2005) gives a review of this work and discusses the epidemiological studies that have appeared in the medical literature. Each study reports a risk ratio for NSAIDs use vs. no NSAIDs use. This risk ratio is either simply an odds ratio obtained from a case-control study or an odds ratio based on a multiple logistic regression analysis that takes into account important risk factors for colon cancer.
It is not surprising that the studies give inconsistent results, since there is heterogeneity in the subject pools (characteristics such as age, ethnicity, and health status vary across the studies), and in the way the data were obtained (covariates to collect, statistical method to use, etc.). It is certainly of interest to carry out a meta-analysis of these studies, and because of the heterogeneity, it seems clear that the meta-analysis should be based on a random effects model. There have been some meta-analyses in the medical literature, but these were very informal: none have used a random effects model (all used fixed effects)
and they have dealt with the conflicting conclusions in ad hoc ways, for example by simply throwing out studies with outlying results. NSAIDs intake and risk of colon cancer. For each study, the following information is given:
• Observed risk ratio for NSAIDs use vs. no NSAIDs use.
• Confidence interval for true risk ratio (this is equivalent to giving the standard error for the estimate).
• Type of NSAID used.
• Dose of NSAID. This information is available for some, but not all, of the studies.
We will carry out two analyses of this data set, in order to illustrate how apparent nonnormality and outliers affect the choice of model to be used, and the effect that model choice has on inference.
We follow convention and work on the log scale, because the normal approximation to the distribution of a study-specific observed odds ratio is better on that scale. The vertical lines in the left panel of Figure 1 give a visual description of the data. The locations on the x-axis are the observed log odds ratios for the 21 studies, and the heights of the lines are proportional to the reciprocals of the reported standard errors. Also given by the figure is an estimate of the distribution of the study-specific log odds ratios, using a kernel density estimate that is based on the observed log odds ratios, with weights that reflect the estimated standard errors. (This density estimate should be viewed with caution, since it is based on the estimated log odds ratios, and not the log odds ratios themselves.) We note that there are two left outliers and one right outlier, although whether or not these are significant enough to warrant using a t distribution remains to be seen.
The dose variable is available for all 15 studies for which the NSAID is aspirin, but is not available for any of the other studies. This variable turns out to be quite important, and none of the reviews in the medical literature have considered it. For each study j, let L j , ω j , and x j denote the observed log risk ratio, standard error, and dose, respectively, for that study. Let ξ j denote the true log risk ratio, i.e. ξ j is the log risk ratio that would be obtained if the sample sizes for study j were infinite. We consider a linear relationship between the latent variable ξ j and the dose x j , i.e. we write ξ j = α j + θ j x j . It is easy to see that α j = 0, since at dose 0 we must have ξ j = 0. So if we start with the model
(justified by standard asymptotic theory), we may write the model equivalently as
Therefore, if we use a t distribution to model the distribution of the θ j 's, we are led to precisely (2.1), with Y j = L j /x j having standard deviation σ j = ω j /x j , and where θ j plays the role of log risk ratio for study j if the dose for that study was equal to 1.
The right panel of Figure 1 gives a visual display of the data for the 15 aspirin studies, with dose taken into account. The deviation from normality now appears stronger. We would like to determine whether for either version of the data set using a t distribution is warranted, and if so determine the degrees of freedom parameter. To this end, for each version of the data set, we ran a Markov chain of length 20,000 based on model ( Figure 1 suggests that for the group of all studies, dose not taken into account, outliers are present, the plot in the left panel of Figure 2 does not indicate that a t distribution is needed. The situation is different for the aspirin studies, where dose is taken into account. The right panel in Figure 2 suggests that one should use a t distribution, with about 3 degrees of freedom.
Before settling on the model based on the t 3 distribution for the aspirin studies, we consider a model in which the non-normality of the random effects is handled through a Dirichlet process prior. Specifically, we replace line (2.1b) with To estimate h, we may proceed as we did before, i.e. fix a value h 1 = (M 1 , d 1 ) and define B(h, h 1 ) = m h /m h 1 . Now let ρ h be the distribution of (θ, µ, λ θ ) under the model specified by the mixture of Dirichlet processes. This distribution is not absolutely continuous with respect to Lebesgue measure on R K ×R×R + , because there is positive probability that the θ i 's are not all distinct, but for h = h 1 , ρ h is absolutely continuous with respect to ρ h 1 , and Doss (2009) 
and Γ is the gamma function. it is based on only the distinct values of θ 1 , . . . , θ K . The term in the second set of braces on the right side of (4.2) does not involve (θ, µ, λ θ ), so is a constant that can be ignored.
To estimate B(h, h 1 ) as h = (M, d) varies, we proceed as we did before. Suppose that
θ ), i = 1, . . . , n is an ergodic Markov chain whose stationary distribution is the posterior distribution of (θ, µ, λ θ ) under the mixture of Dirichlet processes model. We form the estimate (1.5), except that the ratio of densities is replaced by the Radon-Nikodym
The estimate is valid, because the integral in (1.4) is still 1 if the ratio of densities is replaced by the Radon-Nikodym derivative, and the integration is with respect to the probability measure ρ h 1 . There are many algorithms for generating Markov chains for this model. We will not discuss these algorithms and instead refer to Jain and Neal (2007) for a review and recent developments. Using our own implementation, we ran a Markov chain of length 100,000 under the model indexed by M 1 = 3 and d 1 = 3. there is no need for a model based on mixtures of Dirichlet processes, and that in fact the outliers are adequately accommodated by simply using a t 3 distribution.
We therefore ran Markov chains to estimate the posterior distributions under model (2.1) with a t 3 distribution in (2.1b) and also with a normal distribution in (2.1b), for the aspirin Bayes factor is highest for the t 3 distribution, with M = ∞, which corresponds simply to a parametric model based on the t 3 distribution. studies (dose taken into account). From the output, estimates of various quantities of interest can be obtained. In particular, we considered the predictive distribution of the log risk ratio for a future study (this quantity is of special interest in a meta-analysis that uses a random effects model, because in this case the unit is the study and not the individual in a study). Figure 4 shows the predictive distribution of the log risk ratio for a future study for the normal and t 3 models. As can be seen from the figure, the t 3 model gives stronger evidence of the effectiveness of aspirin: the distribution of θ new is shifted to the left and also has significantly less spread. This is because the study for which the log risk ratio is .4 (see Figure 1 (B)) has less influence in the t 3 model. (When the influential study is removed, the two distributions are virtually identical. Also, for the full data set of 21 studies, where dose is not taken into account, the normal and t d distributions for d ≥ 3 all give essentially the same inferences, and this is consistent with the plot in Figure 2 (A) ). With the Markov chain lengths of 10 5 that we used and the method of batching (using 40 batches), standard errors for all four quantities in the figure legend are less than .004. Figure 4: Distribution of θ new , the log risk ratio for a future aspirin study, under the normal and t 3 models. Here, p = P (θ new > 0) and m stands for mean.
Discussion
Before the MCMC revolution, when classical Monte Carlo methods based on iid samples were used to estimate intractable integrals, it would have been deemed unacceptable to report a Monte Carlo estimate without an accompanying asymptotic standard error (based on the CLT). Unfortunately, this seems to have changed with the advent of MCMC. In fact, it is actually uncommon to see an MCMC estimate accompanied by a standard error. Indeed, estimates." This is due at least in part to the fact that it is harder, both theoretically and methodologically, to deal with the standard error problem in the MCMC context. Indeed, it is far more difficult to prove that MCMC-based estimates obey CLTs and, even when such a CLT is known to exist, finding consistent estimates of the variance in the CLT is not straightforward (see, e.g., Geyer 1992 and Jones et al. 2006) . The cleanest way of establishing CLTs for MCMC-based estimators is to prove that the underlying Markov chain converges at a geometric rate (Chan and Geyer 1994; Rosenthal 1997, 1998) .
Unfortunately, this is generally very difficult in the setting of continuous state spaces, and it is therefore not surprising that very few of the MCMC algorithms that are currently used in statistical applications are known to be geometrically ergodic. The exceptions include the MCMC algorithms studied by Mengersen and Tweedie (1996) , Roberts and Tweedie (1996) , Hobert and Geyer (1998) , Roy and Hobert (2007) , Marchev and Hobert (2004) , Roberts and Rosenthal (1999) , Jarner and Hansen (2000) , and Papaspiliopoulos and Roberts (2008) . (It should be noted that there is not a single result in the literature that gives geometric ergodicity for any of the Markov chains used to estimate the posterior distribution in mixture of Dirichlet process models such as the one we considered in Section 4. A comparison of the various chains through a theoretical evaluation is an interesting problem, but one we believe is difficult.)
